
Jay Piccirillo, MD
@piccirillojay
Professor, Vice Chair Research, and Director, Clinical Outcomes Research Office @wustl_ent; Program Director for TL1, R25 @wustlmed. Editor @jamaOTO.
ID: 1231984111037943808
https://otolaryngologyoutcomesresearch.wustl.edu 24-02-2020 16:48:21
506 Tweet
1,1K Takipçi
891 Takip Edilen

Congratulations to Dr. Lauren Roland - New Fellow of the Triological Society & winner of the Fowler Award for her candidate’s thesis with Dr. Matt Shew and myself at the 127th Annual Meeting in New Orleans WashUMedENT


Congratulations to WashUMedENT resident Dr. Andrew Peterson on winning the top poster award for the American Head and Neck Society at COSM in New Orleans. His data helps settle the debate of unilateral vs. bilateral transoral surgery for tonsil SCCa Andrew Peterson, MD, MSCI



Please join us in congratulating Sid Puram, MD PhD (Puram Lab), on his promotion to Professor of Otolaryngology and Genetics.


Exciting news in the head and neck cancer space. KEYNOTE-689 resulted in the first FDA approval for patients with HNSCC in 6 years. Congrats to Ravi Uppaluri, MDPhD, Doug Adkins, and the rest of the team worldwide. fda.gov/drugs/resource…

We are pleased to share our RCT data assessing the efficacy of stellate ganglion block for COVID-19-associated parosmia. We strongly do not recommend this widely used treatment based on our results. JAMA Otolaryngology – Head & Neck Surgery WashUMedENT jamanetwork.com/journals/jamao…

Here it is! KEYNOTE-689 primary publication online now NEJM. It’s been an incredible journey with DAdkins Siteman Cancer Center @WUSM. All started in early 2010s / now with U.S. FDA approval and a new standard of care! Dana-Farber News Brigham and Women's Hospital Brigham and Women’s Department of Surgery



This study of 308 HNSCCa pts found no difference in multiple survival outcomes in patients receiving radiotherapy with carboplatin/paclitaxel (C/P) vs cisplatin. C/P may be an ideal alternative regimen in pts who cannot tolerate cisplatin JAMA Otolaryngology – Head & Neck Surgery jamanetwork.com/journals/jamao…

This exciting study out of Europe demonstrates a favorable prognosis in patients >70 years of age with HPV+ OPSCCa undergoing primary surgical therapy. Surgery remains an effective upfront treatment regardless of age JAMA Otolaryngology – Head & Neck Surgery jamanetwork.com/journals/jamao…

With Andrew Peterson at Resident Graduation Dinner. Andrew won First Place for Clinical Presentation at our Ogura Resident Research Day! WashUMedENT Andrew Peterson, MD, MSCI


Dr. P, Dr. Kallogjeri, research staff, and trainees at Outcomes Summer Retreat WashUMedENT


The Summer Research Symposium was a wonderful opportunity for our TL1 trainees to gather and showcase their work. A big thank you to TL1 Program Director Jay Piccirillo, MD, our dedicated mentors, and our hardworking trainees from WashU, Mizzou, Saint Louis University, University of Health Sciences and Pharmacy in STL, & UMKC!


Great time at Vanderbilt Surgeon-Scientist Symposium meeting with medical students in attendance VUMC Otolaryngology–Head and Neck Surgery


Thanks to Aaron Moberly for putting on a great Surgeon-Scientist Symposium at Vanderbilt VUMC Otolaryngology–Head and Neck Surgery


This summer's ASPIRE cohort truly impressed us with their rigorous training, commitment to their projects, and delivery of phenomenal final presentations! Thank you to Dr. Jay Piccirillo, MD for his amazing leadership, and to all of our mentors and trainees!


We’re pleased to share 2 new papers from the WashU H&N Tumor Center Siteman Cancer Center We explored the debate of UL vs. BL transoral surgery for tonsillar SCCa through a WashU cohort and meta-analysis. Is it time we stop routinely removing the non-diseased tonsil? WashUMedENT
